Transforming healthcare may feel like something that is too hard, too complex, or too costly to implement but the real cost of inertia can be counted in the lives of people affected by and living with chronic, acute, communicable and non-communicable diseases.
At Roche, we believe that partnership and collaboration is key to realise the future of healthcare, today. We work closely with regulators, payers, medical institutions, providers, researchers and patients to understand their perspectives and challenges, and to co-create value-based healthcare models that improve outcomes and access for all. We actively seek partnerships and collaborations with academia, governments, regulators, health services and healthcare companies, so we can jointly find ways to transform patients’ lives for the better.
Hence, we are very excited to announce our newest partner,
Nasri Nahas, CEO of Biopôle SA, comments, “We’re thrilled to enter into this partnership with Roche Pharma Switzerland. Our strong network will offer Roche many opportunities to broaden their network, while our community will benefit from their national and worldwide market research and scientific expertise.”
Dr. med. Katharina Gasser, General Manager Roche Pharma Switzerland says: "We are delighted to be part of this community that strengthens Switzerland, and in particular the French-speaking part of the country, as a leading centre for innovation and life sciences. By increasing the chances of bringing transformative benefits to countless people living with chronic and acute diseases.”
We are confident and look forward to future innovations that will emerge from this partnership, which will optimise healthcare in Switzerland and thus make a significant contribution to the well-being of society.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.